within Pharmacolibrary.Drugs.ATC.D;

model D04AA09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.004166666666666667,
    adminDuration  = 600,
    adminMass      = 0.025,
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0011666666666666668,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Chloropyramine is a first-generation antihistamine of the ethylenediamine class. It is used as an antiallergic drug for the treatment of allergic reactions, including urticaria, hay fever, angioedema, and allergic conjunctivitis. Chloropyramine is currently used mainly in Eastern Europe and post-Soviet countries. It is largely unavailable or withdrawn in most Western countries.</p><h4>Pharmacokinetics</h4><p>No peer-reviewed publication provides primary pharmacokinetic parameters for chloropyramine in humans. The following estimates are extrapolated from limited summaries, datasheets, and analogous first-generation antihistamines in adults after oral administration.</p><h4>References</h4><ol><li><p>Wilton, J, et al., &amp; Fetterly, G (2016). Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs. <i>European journal of drug metabolism and pharmacokinetics</i> 41(1) 55–67. DOI:<a href=&quot;https://doi.org/10.1007/s13318-014-0233-6&quot;>10.1007/s13318-014-0233-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25377246/&quot;>https://pubmed.ncbi.nlm.nih.gov/25377246</a></p></li><li><p>Bender, KI, &amp; Lutsevich, AN (1988). [Dependence of the absorption through the human oral mucosa of antihistaminic (H1) preparations on their physicochemical properties]. <i>Farmakologiia i toksikologiia</i> 51(1) 75–79. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2896132/&quot;>https://pubmed.ncbi.nlm.nih.gov/2896132</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D04AA09;
